- Baratto-Roldan, Anna
- Cortés-Giraldo, Miguel Antonio
- Jiménez-Ramos, M. C.
- García López, J.
- Gallardo, María Isabel
- Espino, J. M.
Trabajo presentado en Rábida 2018: International Scientific Meeting on Nuclear Physics, celebrado en La Rábida (Sevilla, España), del 18 al 22 de junio de 2018, In the last decades, particle radiation therapy, mainly performed with protons and carbon ions, has
gained great interest in the medical community thanks to its excellent clinical results. The bases of
this success are: (1) the physical advantages of protons and heavier ions with respect to conventional
radiation therapy with photons, due to their more selective energy deposition in depth; and (2) their
increased radiobiological effectiveness, since protons and heavier ions offer a higher cell-killing
effectiveness if compared to photons for a same level of absorbed dose, property usually referred to
as Relative Biological Effectiveness or RBE.
The RBE depends on different factors, both physical and biological, such as radiation quality,
track structure, linear energy transfer (LET), tissue type, biological endpoint, etc. However, in the
case of protons, there is still place for improvements in what concerns the understanding of the
behaviour of the RBE on both cancer and healthy cells, and its role in treatment planning and delivery.
Even if it is agreed that proton RBE varies towards the distal Bragg peak region, increasing with LET,
nowadays in clinical proton therapy treatments, a uniform RBE value of 1.1 is generally used,
leading possibly to suboptimal proton treatment plans, as stated in Wedenberg et al. Therefore,
studies of RBE at low proton energies are necessary in order to optimize proton therapy treatment
plans and reach a consensus on the RBE variations near the Bragg peak.
However, not many proton facilities can provide a monochromatic beam for radiobiological
measurements at low energies (roughly below 20 MeV). With this purpose, we are preparing an
experimental setup at the external beam line of the 18MeV proton cyclotron facility installed at the
CNA (Seville, Spain) to cover this gap.
[Methods and Results] In this work, we present our first feasibility studies. At present, the experimental beam line
installed at the cyclotron facility counts on two Faraday cups for beam diagnostics, and on two
collimators of 1.5 cm diameter placed at 1 m distance one from the other, the second of them mounted
together with a 100 µm Aluminium exit window, for beam delivery and shaping.
Two are the main constraints when dealing with cell irradiations: low beam intensity, of the order
of some pA, to control properly the fluence during irradiation time, and broad irradiation field, of the
order of 3cm side, uniform in both energy and space. In order to improve the homogeneity and
decrease the beam intensity, we have decided to use a completely defocused beam and to scatter the
beam downstream the exit window, both placing tungsten foils of different thicknesses and changing
the amount of air between the window and the samples position.
So far, we have measured the properties of wide beams produced with tungsten scattering foils of
various thicknesses. With a 150 m thick tungsten foil, we could produce a 10 MeV proton beam
with almost homogeneous intensity, having deviations of the order of ~10% in the central 35 mm and
at ~50 cm distance from the exit window. Furthermore, we have performed preliminary dosimetric
studies, using EBT3 radiochromic films and a transmission ionization chamber for dose and proton
fluence evaluation. Studies of this nature are of great interest, since radiochromic films would be a
handy and easy to use dosimeter solution for proton RBE studies.
Finally, we are developing with the Geant4 toolkit a Monte Carlo tool, which reproduces accurately the cyclotron beam properties with the aim of simulating future improvements proposed
on the final optimization of the setup for the irradiation of biological samples., This project has received funding from the European Union’s Horizon 2020 research and
innovation programme under the Marie Sklodowska-Curie grant agreement No 675265, OMA
Optimization of Medical Accelerators, and from the Spanish Ministry of Economy and
Competitiveness under grand No FPA2016-77689-C2-1-R. The Monte Carlo simulations were
carried out at the FIS-ATOM cluster hosted at CICA (Seville, Spain)., Peer reviewed